---
document_datetime: 2023-09-21 21:03:51
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/nucala-epar-all-authorised-presentations_en.pdf
document_name: nucala-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4779907
conversion_datetime: 2025-12-20 02:26:12.69002
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/15/1043/001   | Nucala   | 100 mg   | Powder for solution for injection   | Subcutaneous use   | vial (glass)                                 | 100 mg                | 1 vial                                     |
|--------------------|----------|----------|-------------------------------------|--------------------|----------------------------------------------|-----------------------|--------------------------------------------|
| EU/1/15/1043/002   | Nucala   | 100 mg   | Powder for solution for injection   | Subcutaneous use   | vial (glass)                                 | 100 mg                | 3 (3 x 1) vials (multipack)                |
| EU/1/15/1043/003   | Nucala   | 100 mg   | Solution for injection              | Subcutaneous use   | Pre-filled syringe (glass) in pre-filled pen | 1 ml (100 mg/ml)      | 1 pre-filled pen                           |
| EU/1/15/1043/004   | Nucala   | 100 mg   | Solution for injection              | Subcutaneous use   | Pre-filled syringe (glass) in pre-filled pen | 1 ml (100 mg/ml)      | 3 (3 x 1) pre- filled pens (multipack)     |
| EU/1/15/1043/005   | Nucala   | 100 mg   | Solution for injection              | Subcutaneous use   | Pre-filled syringe (glass)                   | 1 ml (100 mg/ml)      | 1 pre-filled syringe                       |
| EU/1/15/1043/006   | Nucala   | 100 mg   | Solution for injection              | Subcutaneous use   | Pre-filled syringe (glass)                   | 1 ml (100 mg/ml)      | 3 (3 x 1) pre- filled syringes (multipack) |
| EU/1/15/1043/007   | Nucala   | 100 mg   | Solution for injection              | Subcutaneous use   | Pre-filled syringe (glass) in pre-filled pen | 1 ml (100 mg/ml)      | 9 (9 x 1) pre- filled pens (multipack)     |
| EU/1/15/1043/008   | Nucala   | 100 mg   | Solution for injection              | Subcutaneous use   | Pre-filled syringe (glass)                   | 1 ml (100 mg/ml)      | 9 (9 x 1) pre- filled syringes (multipack) |
| EU/1/15/1043/009   | Nucala   | 40 mg    | Solution for injection              | Subcutaneous use   | Pre-filled syringe (glass)                   | 0.4 ml (40 mg/0.4 ml) | 1 pre-filled syringe                       |
| EU/1/15/1043/010   | Nucala   | 40 mg    | Solution for injection              | Subcutaneous use   | Pre-filled syringe (glass)                   | 0.4 ml (40 mg/0.4 ml) | 3 (3 x 1) pre- filled syringes (multipack) |